Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MINERVA SURGICAL INCUTRS · Entity 115564 | Director | July 19, 2022 | August 09, 2022 |
| Pulmonx CorpLUNG · Entity 2359 | COO and CFO | December 01, 2025 | December 04, 2025 |
| iRhythm Holdings, Inc.IRTC · Entity 1499 | EVP, Strat Corp Development | February 27, 2019 | March 18, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MINERVA SURGICAL INC
Report date July 19, 2022 · Filed August 09, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 86,956 |
Reported balance
After 2022-07-19 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2022-07-19 · Grant · Acquired 86,956 · Balance 86,956 F1: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. Each RSU award will vest in twelve equal quarterly installments on the quarterly anniversary of the grant date, subject to the Reporting Person continuing as a service provider through each such date. |
Filing footnotes · ownership attribution and instrument terms
F1: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. Each RSU award will vest in twelve equal quarterly installments on the quarterly anniversary of the grant date, subject to the Reporting Person continuing as a service provider through each such date.
Pulmonx Corp
Report date December 01, 2025 · Filed December 04, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,335,319 |
Reported balance
After 2025-12-01 transaction · row 1
1 source rowRow 1 · 2025-12-01 · Grant · Acquired 1,200,000 · Balance 1,335,319 F1: Represents grant of Restricted Stock Units payable solely in common stock of the Issuer, 25% of which vests one year from the grant date of December 1, 2025, and the remainder vests in equal quarterly installments over the three-year period following the date of grant. |
| Performance Stock UnitsSEC Table II · derivative / convertible security · Expires 2028-12-01 | Direct | 400,000 |
Reported balance
After 2025-12-01 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-12-01 · Grant · Acquired 400,000 · Balance 400,000 F2: Each Performance Stock Unit represents a contingent right to receive one share of the Issuer's common stock. The Performance Stock Units vest upon meeting the following two conditions: (a) upon the Issuer's common stock achieving a specified price per share and (b) with respect to 33% on the one year following the grant date of December 1, 2025 and the remainder in eight equal quarterly installments. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents grant of Restricted Stock Units payable solely in common stock of the Issuer, 25% of which vests one year from the grant date of December 1, 2025, and the remainder vests in equal quarterly installments over the three-year period following the date of grant.
F2: Each Performance Stock Unit represents a contingent right to receive one share of the Issuer's common stock. The Performance Stock Units vest upon meeting the following two conditions: (a) upon the Issuer's common stock achieving a specified price per share and (b) with respect to 33% on the one year following the grant date of December 1, 2025 and the remainder in eight equal quarterly installments.
iRhythm Holdings, Inc.
Report date February 27, 2019 · Filed March 18, 2019 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 26,983 |
Reported balance
After 2019-02-27 transaction · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · 2019-02-27 · Grant · Acquired 1,725 · Balance 26,983 F1: The reported securities are represented by restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of IRTC common stock. This amendment is filed to set forth the correct vesting schedule of the RSUs, which is 25% of the shares on March 1, 2020 and each one-year anniversary thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: The reported securities are represented by restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of IRTC common stock. This amendment is filed to set forth the correct vesting schedule of the RSUs, which is 25% of the shares on March 1, 2020 and each one-year anniversary thereafter.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 01, 2025 Filed Dec 4, 2025 00:45 UTC | Pulmonx Corp LUNG · Entity 2359 | GrantPerformance Stock Units · Derivative | 400,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001670118-25-000006 · form4-12042025_121248.xml · derivative · entry 2 Sung Derrick · CIK 0001670118 · COO and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 400,000 Underlying: Common Stock · 400,000 shares Expires 2028-12-01 F2 · derivative.exercise_price: Each Performance Stock Unit represents a contingent right to receive one share of the Issuer's common stock. The Performance Stock Units vest upon meeting the following two conditions: (a) upon the Issuer's common stock achieving a specified price per share and (b) with respect to 33% on the one year following the grant date of December 1, 2025 and the remainder in eight equal quarterly installments. F2 · derivative.exercise_date: Each Performance Stock Unit represents a contingent right to receive one share of the Issuer's common stock. The Performance Stock Units vest upon meeting the following two conditions: (a) upon the Issuer's common stock achieving a specified price per share and (b) with respect to 33% on the one year following the grant date of December 1, 2025 and the remainder in eight equal quarterly installments. Read SEC document |
| December 01, 2025 Filed Dec 4, 2025 00:45 UTC | Pulmonx Corp LUNG · Entity 2359 | GrantCommon Stock | 1,200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001670118-25-000006 · form4-12042025_121248.xml · nonDerivative · entry 1 Sung Derrick · CIK 0001670118 · COO and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,335,319 F1 · shares: Represents grant of Restricted Stock Units payable solely in common stock of the Issuer, 25% of which vests one year from the grant date of December 1, 2025, and the remainder vests in equal quarterly installments over the three-year period following the date of grant. Read SEC document |
| September 01, 2023 Filed Sep 6, 2023 22:07 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 3,120 | $10.00 | $31,200.00 |
DisclosureSEC source: 0001209191-23-048516 · doc4.xml · nonDerivative · entry 3 Sung Derrick · CIK 0001670118 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 391,041 F3 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2023. Read SEC document |
| September 01, 2023 Filed Sep 6, 2023 22:07 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 701 | $10.01 | $7,017.01 |
DisclosureSEC source: 0001209191-23-048516 · doc4.xml · nonDerivative · entry 2 Sung Derrick · CIK 0001670118 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 394,161 F2 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2022. Read SEC document |
| September 01, 2023 Filed Sep 6, 2023 22:07 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 398 | $10.01 | $3,983.98 |
DisclosureSEC source: 0001209191-23-048516 · doc4.xml · nonDerivative · entry 1 Sung Derrick · CIK 0001670118 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 394,862 F1 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units (the "RSUs") granted on June 1, 2021. Read SEC document |
| June 01, 2023 Filed Jun 2, 2023 22:51 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 3,122 | $11.49 | $35,871.78 |
DisclosureSEC source: 0001209191-23-034010 · doc4.xml · nonDerivative · entry 3 Sung Derrick · CIK 0001670118 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 395,260 F3 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2023. Read SEC document |
| June 01, 2023 Filed Jun 2, 2023 22:51 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 701 | $11.49 | $8,054.49 |
DisclosureSEC source: 0001209191-23-034010 · doc4.xml · nonDerivative · entry 2 Sung Derrick · CIK 0001670118 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 398,382 F2 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2022. Read SEC document |
| June 01, 2023 Filed Jun 2, 2023 22:51 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 399 | $11.48 | $4,580.52 |
DisclosureSEC source: 0001209191-23-034010 · doc4.xml · nonDerivative · entry 1 Sung Derrick · CIK 0001670118 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 399,083 F1 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units (the "RSUs") granted on June 1, 2021. Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 00:09 UTC | Pulmonx Corp LUNG · Entity 2359 | GrantEmployee Stock Option (right to buy) · Derivative | 94,500 | $0.00 Strike: $11.48 | $0.00 |
DisclosureSEC source: 0001209191-23-016025 · doc4.xml · derivative · entry 4 Sung Derrick · CIK 0001670118 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,500 Underlying: Common Stock · 94,500 shares Expires 2033-02-28 F4 · derivative.exercise_date: The shares subject to the option vest in 48 equal monthly installments beginning on March 1, 2023. Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 00:09 UTC | Pulmonx Corp LUNG · Entity 2359 | GrantCommon Stock | 138,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-016025 · doc4.xml · nonDerivative · entry 3 Sung Derrick · CIK 0001670118 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 399,482 F3 · shares: Represents grant of Restricted Stock Units payable solely in common stock of the Issuer that vest over four years in equal quarterly installments beginning on March 1, 2023. Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 00:09 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 806 | $11.03 | $8,890.18 |
DisclosureSEC source: 0001209191-23-016025 · doc4.xml · nonDerivative · entry 2 Sung Derrick · CIK 0001670118 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 261,482 F2 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units granted on March 1, 2022. Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 00:09 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 458 | $11.03 | $5,051.74 |
DisclosureSEC source: 0001209191-23-016025 · doc4.xml · nonDerivative · entry 1 Sung Derrick · CIK 0001670118 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 262,288 F1 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units granted on June 1, 2021. Read SEC document |
| December 01, 2022 Filed Dec 5, 2022 23:35 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 682 | $5.93 | $4,044.26 |
DisclosureSEC source: 0001209191-22-059842 · doc4.xml · nonDerivative · entry 2 Sung Derrick · CIK 0001670118 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 262,746 F2 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units granted on March 1, 2022. Read SEC document |
| December 01, 2022 Filed Dec 5, 2022 23:35 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 387 | $5.93 | $2,294.91 |
DisclosureSEC source: 0001209191-22-059842 · doc4.xml · nonDerivative · entry 1 Sung Derrick · CIK 0001670118 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 263,428 F1 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units granted on June 1, 2021. Read SEC document |
| November 14, 2022 Filed Nov 15, 2022 01:06 UTC | Pulmonx Corp LUNG · Entity 2359 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $2.20 | $0.00 |
DisclosureSEC source: 0001209191-22-056872 · doc4.xml · derivative · entry 2 Sung Derrick · CIK 0001670118 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 10,000 shares Expires 2030-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The shares subject to the option are immediately exercisable and vest in 48 equal monthly installments beginning on August 28, 2020, subject to the Reporting Person's continuous service through each such vesting date. Read SEC document |
| November 14, 2022 Filed Nov 15, 2022 01:06 UTC | Pulmonx Corp LUNG · Entity 2359 | Exercise / conversionCommon Stock | 10,000 | $2.20 | $22,000.00 |
DisclosureSEC source: 0001209191-22-056872 · doc4.xml · nonDerivative · entry 1 Sung Derrick · CIK 0001670118 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 263,815 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 01, 2022 Filed Sep 6, 2022 20:53 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 690 | $17.87 | $12,330.30 |
DisclosureSEC source: 0001209191-22-048783 · doc4.xml · nonDerivative · entry 2 Sung Derrick · CIK 0001670118 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 253,815 F2 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units granted on March 1, 2022. Read SEC document |
| September 01, 2022 Filed Sep 6, 2022 20:53 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 392 | $17.87 | $7,005.04 |
DisclosureSEC source: 0001209191-22-048783 · doc4.xml · nonDerivative · entry 1 Sung Derrick · CIK 0001670118 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 254,505 F1 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units granted on June 1, 2021. Read SEC document |
| July 19, 2022 Filed Aug 9, 2022 21:20 UTC | MINERVA SURGICAL INC UTRS · Entity 115564 | GrantCommon Stock | 86,956 | $2.30 | $199,998.80 |
DisclosureSEC source: 0001209191-22-045119 · doc4.xml · nonDerivative · entry 1 Sung Derrick · CIK 0001670118 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,956 F1 · shares: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. Each RSU award will vest in twelve equal quarterly installments on the quarterly anniversary of the grant date, subject to the Reporting Person continuing as a service provider through each such date. F1 · balance_after: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. Each RSU award will vest in twelve equal quarterly installments on the quarterly anniversary of the grant date, subject to the Reporting Person continuing as a service provider through each such date. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 22:07 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 679 | $18.05 | $12,255.95 |
DisclosureSEC source: 0001209191-22-034310 · doc4.xml · nonDerivative · entry 2 Sung Derrick · CIK 0001670118 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 254,897 F2 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units granted on March 1, 2022. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 22:07 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 386 | $18.05 | $6,967.30 |
DisclosureSEC source: 0001209191-22-034310 · doc4.xml · nonDerivative · entry 1 Sung Derrick · CIK 0001670118 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 255,576 F1 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units granted on June 1, 2021. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 23:14 UTC | Pulmonx Corp LUNG · Entity 2359 | GrantEmployee Stock Option (right to buy) · Derivative | 68,700 | $0.00 Strike: $26.56 | $0.00 |
DisclosureSEC source: 0001209191-22-015840 · doc4.xml · derivative · entry 3 Sung Derrick · CIK 0001670118 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,700 Underlying: Common Stock · 68,700 shares Expires 2032-02-29 F2 · derivative.exercise_date: The shares subject to the option vest in 48 equal monthly installments beginning on March 1, 2022. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 23:14 UTC | Pulmonx Corp LUNG · Entity 2359 | GrantCommon Stock | 31,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-015840 · doc4.xml · nonDerivative · entry 2 Sung Derrick · CIK 0001670118 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 255,962 F1 · shares: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units granted on June 1, 2021. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 23:14 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 458 | $25.91 | $11,866.78 |
DisclosureSEC source: 0001209191-22-015840 · doc4.xml · nonDerivative · entry 1 Sung Derrick · CIK 0001670118 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 224,962 F1 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units granted on June 1, 2021. Read SEC document |
| December 15, 2021 Filed Dec 16, 2021 22:48 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 24 | $31.58 | $757.92 |
DisclosureSEC source: 0001209191-21-070035 · doc4.xml · nonDerivative · entry 3 Sung Derrick · CIK 0001670118 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 225,420 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| December 15, 2021 Filed Dec 16, 2021 22:48 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 2,976 | $30.52 | $90,827.52 |
DisclosureSEC source: 0001209191-21-070035 · doc4.xml · nonDerivative · entry 2 Sung Derrick · CIK 0001670118 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 225,444 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.36 to $31.07, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| December 14, 2021 Filed Dec 16, 2021 22:48 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 3,000 | $32.89 | $98,670.00 |
DisclosureSEC source: 0001209191-21-070035 · doc4.xml · nonDerivative · entry 1 Sung Derrick · CIK 0001670118 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 228,420 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.39 to $33.27, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| December 01, 2021 Filed Dec 3, 2021 23:34 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 383 | $32.73 | $12,535.59 |
DisclosureSEC source: 0001209191-21-067970 · doc4.xml · nonDerivative · entry 1 Sung Derrick · CIK 0001670118 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 231,420 F1 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units granted on June 1, 2021. Read SEC document |
| September 21, 2021 Filed Sep 22, 2021 00:11 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 3,000 | $37.50 | $112,500.00 |
DisclosureSEC source: 0001209191-21-057147 · doc4.xml · nonDerivative · entry 3 Sung Derrick · CIK 0001670118 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 231,803 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2020, as amended August 20, 2021. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.30 to $37.74, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| September 20, 2021 Filed Sep 22, 2021 00:11 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 115 | $37.96 | $4,365.40 |
DisclosureSEC source: 0001209191-21-057147 · doc4.xml · nonDerivative · entry 2 Sung Derrick · CIK 0001670118 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 234,803 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2020, as amended August 20, 2021. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.86 to $37.98, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| September 20, 2021 Filed Sep 22, 2021 00:11 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 2,885 | $37.33 | $107,697.05 |
DisclosureSEC source: 0001209191-21-057147 · doc4.xml · nonDerivative · entry 1 Sung Derrick · CIK 0001670118 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 234,918 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2020, as amended August 20, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.81 to $37.77, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| September 01, 2021 Filed Sep 3, 2021 21:58 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 383 | $40.09 | $15,354.47 |
DisclosureSEC source: 0001209191-21-054861 · doc4.xml · nonDerivative · entry 1 Sung Derrick · CIK 0001670118 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 237,803 F1 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units granted on June 1, 2021. Read SEC document |
| June 01, 2021 Filed Jun 12, 2021 00:24 UTC | Pulmonx Corp LUNG · Entity 2359 | GrantEmployee Stock Option (right to buy) · Derivative | 39,900 | $0.00 Strike: $43.40 | $0.00 |
DisclosureSEC source: 0001209191-21-040077 · doc4.xml · derivative · entry 2 Sung Derrick · CIK 0001670118 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,900 Underlying: Common Stock · 39,900 shares Expires 2031-05-31 F3 · derivative.exercise_date: The shares subject to the option vest in 48 equal monthly installments beginning on June 1, 2021. Read SEC document |
| June 01, 2021 Filed Jun 12, 2021 00:24 UTC | Pulmonx Corp LUNG · Entity 2359 | GrantCommon Stock | 17,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-040077 · doc4.xml · nonDerivative · entry 1 Sung Derrick · CIK 0001670118 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 238,186 F1 · shares: Represents grant of Restricted Stock Units payable solely in common stock of the Issuer that vest over four years in equal quarterly installments beginning on June 1, 2021. F2 · balance_after: Includes 1,927 shares acquired by the Reporting Person under the Issuer's 2020 Employee Stock Purchase Plan on May 24, 2021. Read SEC document |
| April 06, 2021 Filed Apr 6, 2021 23:40 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 600 | $48.33 | $28,998.00 |
DisclosureSEC source: 0001209191-21-025747 · doc4.xml · nonDerivative · entry 5 Sung Derrick · CIK 0001670118 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 218,659 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2020. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.305 to $48.35, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| April 06, 2021 Filed Apr 6, 2021 23:40 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 1,575 | $47.79 | $75,269.25 |
DisclosureSEC source: 0001209191-21-025747 · doc4.xml · nonDerivative · entry 4 Sung Derrick · CIK 0001670118 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 219,259 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2020. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.29 to $48.11, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| April 06, 2021 Filed Apr 6, 2021 23:40 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 2,825 | $46.49 | $131,334.25 |
DisclosureSEC source: 0001209191-21-025747 · doc4.xml · nonDerivative · entry 3 Sung Derrick · CIK 0001670118 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 220,834 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2020. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.162 to $46.87, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| April 05, 2021 Filed Apr 6, 2021 23:40 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 220 | $48.56 | $10,683.20 |
DisclosureSEC source: 0001209191-21-025747 · doc4.xml · nonDerivative · entry 2 Sung Derrick · CIK 0001670118 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 223,659 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2020. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.435 to $48.95, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| April 05, 2021 Filed Apr 6, 2021 23:40 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 4,780 | $47.56 | $227,336.80 |
DisclosureSEC source: 0001209191-21-025747 · doc4.xml · nonDerivative · entry 1 Sung Derrick · CIK 0001670118 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 223,879 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.08 to $48.045, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 15:17 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | Tax withholdingCommon Stock | 1,081 | $97.34 | $105,224.54 |
DisclosureSEC source: 0001209191-19-016327 · doc4.xml · nonDerivative · entry 1 Sung Derrick · CIK 0001670118 · EVP, Strat Corp Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,902 F1 · shares: Represents shares that have been withheld by the Issuer to satisfy income tax withholding and remittance obligations in connection with the vesting and net settlement of restricted stock units previously reported. Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 21:36 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | GrantCommon Stock | 1,725 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-015289 · doc4.xml · nonDerivative · entry 1 Sung Derrick · CIK 0001670118 · EVP, Strat Corp Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,983 F1 · shares: The reported securities are represented by restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of IRTC common stock. 100% of the RSUs vest on March 1, 2021. Read SEC document |
| February 27, 2019 Filed Mar 18, 2019 17:57 UTC Amendment | iRhythm Holdings, Inc. IRTC · Entity 1499 | GrantCommon Stock | 1,725 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-020076 · doc4a.xml · nonDerivative · entry 1 Sung Derrick · CIK 0001670118 · EVP, Strat Corp Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,983 F1 · shares: The reported securities are represented by restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of IRTC common stock. This amendment is filed to set forth the correct vesting schedule of the RSUs, which is 25% of the shares on March 1, 2020 and each one-year anniversary thereafter. Read SEC document |
| January 30, 2019 Filed Jan 31, 2019 14:41 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,000 | $0.00 Strike: $35.25 | $0.00 |
DisclosureSEC source: 0001209191-19-006115 · doc4.xml · derivative · entry 3 Sung Derrick · CIK 0001670118 · EVP, Strat Corp Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,875 Underlying: Common Stock · 2,000 shares Expires 2027-02-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 30, 2019 Filed Jan 31, 2019 14:41 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | SaleCommon Stock | 2,000 | $84.00 | $168,000.00 |
DisclosureSEC source: 0001209191-19-006115 · doc4.xml · nonDerivative · entry 2 Sung Derrick · CIK 0001670118 · EVP, Strat Corp Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,258 F1 · kind: The option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 26, 2018. Read SEC document |
| January 30, 2019 Filed Jan 31, 2019 14:41 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | Exercise / conversionCommon Stock | 2,000 | $35.25 | $70,500.00 |
DisclosureSEC source: 0001209191-19-006115 · doc4.xml · nonDerivative · entry 1 Sung Derrick · CIK 0001670118 · EVP, Strat Corp Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,258 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 26, 2018. Read SEC document |
| January 29, 2019 Filed Jan 30, 2019 16:38 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,057 | $0.00 Strike: $35.25 | $0.00 |
DisclosureSEC source: 0001209191-19-006014 · doc4.xml · derivative · entry 8 Sung Derrick · CIK 0001670118 · EVP, Strat Corp Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,875 Underlying: Common Stock · 1,057 shares Expires 2027-02-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 29, 2019 Filed Jan 30, 2019 16:38 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | SaleCommon Stock | 1,057 | $84.03 | $88,821.82 |
DisclosureSEC source: 0001209191-19-006014 · doc4.xml · nonDerivative · entry 5 Sung Derrick · CIK 0001670118 · EVP, Strat Corp Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,258 F1 · kind: The option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 26, 2018. F3 · price: This transaction was executed in multiple trades at prices ranging from $84.00 to $84.20. The prices reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 29, 2019 Filed Jan 30, 2019 16:38 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | Exercise / conversionCommon Stock | 1,057 | $35.25 | $37,259.25 |
DisclosureSEC source: 0001209191-19-006014 · doc4.xml · nonDerivative · entry 4 Sung Derrick · CIK 0001670118 · EVP, Strat Corp Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,315 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 26, 2018. Read SEC document |
| January 28, 2019 Filed Jan 30, 2019 16:38 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 6,000 | $0.00 Strike: $6.35 | $0.00 |
DisclosureSEC source: 0001209191-19-006014 · doc4.xml · derivative · entry 7 Sung Derrick · CIK 0001670118 · EVP, Strat Corp Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,091 Underlying: Common Stock · 6,000 shares Expires 2025-06-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 28, 2019 Filed Jan 30, 2019 16:38 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,068 | $0.00 Strike: $35.25 | $0.00 |
DisclosureSEC source: 0001209191-19-006014 · doc4.xml · derivative · entry 6 Sung Derrick · CIK 0001670118 · EVP, Strat Corp Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,932 Underlying: Common Stock · 3,068 shares Expires 2027-02-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.